R63* (p.Arg63Ter) variant of USH2A (Usherin)

R63* (p.Arg63Ter) in USH2A (Usherin) is a protein-truncating change. Clinical records from EBI and UniProt describe it as pathogenic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data, published literature, and structural context.

R63* (p.Arg63Ter) variant details